Gita Suneja
YOU?
Author Swipe
View article: Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study
Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study Open
View article: Supplemental Table 2 from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers
Supplemental Table 2 from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers Open
Supplemental Table 2: Number of Tumor Samples, and Number (%) Individual Patients, with Tissue Staining Results Available, by Immune Marker and Cancer Type.
View article: Supplemental Table 1 from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers
Supplemental Table 1 from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers Open
Supplemental Table 1: Number of Study Specimens by HIV Status, Cancer Type, and Source.
View article: Data from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers
Data from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers Open
Background:Cancer outcomes in people living with human immunodeficiency virus (PWH) may be driven in part by a distinct tumor microenvironment (TME) for cancers that develop in the setting of persistent immune dysfunction.Methods:Tumor sam…
View article: Supplemental Figure 1 from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers
Supplemental Figure 1 from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers Open
Supplemental Figure 1: Percentage of tumor cells staining positive for immune markers, and age and race-adjusted associations (ORs [95% CI]) between tumor immune marker staining abundance and patient HIV status, by cancer type. All immune …
View article: Comparison of QuPath and HALO platforms for analysis of the tumor microenvironment in prostate cancer
Comparison of QuPath and HALO platforms for analysis of the tumor microenvironment in prostate cancer Open
QuPath, an open-source digital pathology platform, has gained widespread use for image analysis in biomedical research since its release in 2016. However, its reproducibility and reliability compared to commercial software, such as HALO, r…
View article: Inequities by race and ethnicity in cancer treatment receipt among people living with HIV and cancer in the U.S. (2004–2020)
Inequities by race and ethnicity in cancer treatment receipt among people living with HIV and cancer in the U.S. (2004–2020) Open
Objective People with HIV (PWH) are less likely to receive cancer treatment compared to those without HIV. Social factors, such as cancer treatment facility type, which may impact cancer treatment receipt among PWH have not been quantitati…
View article: Radiation Oncology Resident Perspectives on Diversity, Equity, and Inclusion: An Association of Residents in Radiation Oncology Equity and Inclusion Subcommittee Inaugural Resident Survey
Radiation Oncology Resident Perspectives on Diversity, Equity, and Inclusion: An Association of Residents in Radiation Oncology Equity and Inclusion Subcommittee Inaugural Resident Survey Open
View article: Supplemental Figure 1. from Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN)
Supplemental Figure 1. from Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN) Open
Supplemental Figure 1. Average proportion of tumor-specific mutations classified as putative class I neoantigens, according to HIV status and cancer site. Statistical comparisons (p-values) were computed using a Wilcoxon test.
View article: Data from Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN)
Data from Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN) Open
Background:People living with HIV (PWH) have improved life expectancy because of effective human immunodeficiency virus (HIV) therapy but still experience immune impairment (e.g., altered CD4/CD8 T cells). We hypothesized that tumors diagn…
View article: Supplemental Table 1 from Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN)
Supplemental Table 1 from Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN) Open
Supplemental Table 1: Average genomic features by cancer patient HIV status, listed by cancer site
View article: Population analysis and immunologic landscape of melanoma in people living with HIV
Population analysis and immunologic landscape of melanoma in people living with HIV Open
Purpose To dissect the clinical and immunological features of people living with HIV (PLWH) diagnosed with melanoma, who have consistently exhibited worse clinical outcomes than HIV-negative individuals (PLw/oH) with the same cancer. Exper…
View article: Radiation Oncology Residency Training Program Integration of Diversity, Equity, and Inclusion: An Association of Residents in Radiation Oncology Equity and Inclusion Subcommittee Inaugural Program Director Survey
Radiation Oncology Residency Training Program Integration of Diversity, Equity, and Inclusion: An Association of Residents in Radiation Oncology Equity and Inclusion Subcommittee Inaugural Program Director Survey Open
View article: Patterns of Care in Adjuvant Radiation Therapy for Stage II Endometrioid Endometrial Adenocarcinoma: A National Cancer Database Analysis
Patterns of Care in Adjuvant Radiation Therapy for Stage II Endometrioid Endometrial Adenocarcinoma: A National Cancer Database Analysis Open
View article: Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial
Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial Open
PURPOSE Vaginal cuff brachytherapy (VCB) is widely used for adjuvant treatment of endometrial cancer, yet limited randomized data examine the optimal dose/fractionation. We aimed to study short-course VCB using patient-reported outcomes. M…
View article: Inequities in palliative care delivery to patients with HIV and stage IV cancers in the United States (2004-2020)
Inequities in palliative care delivery to patients with HIV and stage IV cancers in the United States (2004-2020) Open
Background People with HIV diagnosed with stage IV cancer are less likely to receive palliative care compared with those without HIV. Our objective was to evaluate inequities in palliative care receipt among people with HIV with stage IV c…
View article: Corrigendum to “Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer” Eur. J. Cancer (201) (April) 2024, 113913
Corrigendum to “Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer” Eur. J. Cancer (201) (April) 2024, 113913 Open
View article: Cancer Treatment Disparities in People With HIV in the United States, 2001-2019
Cancer Treatment Disparities in People With HIV in the United States, 2001-2019 Open
PURPOSE People with HIV (PWH) have worse cancer outcomes, partially because of inequities in cancer treatment. We evaluated cancer treatment disparities among PWH, including an assessment of changes in disparities over time. METHODS We use…
View article: Reducing the Environmental Impact of Health Care Conferences: A Study of Emissions and Practical Solutions
Reducing the Environmental Impact of Health Care Conferences: A Study of Emissions and Practical Solutions Open
PURPOSE We aimed to examine the impact of different conference formats (in-person, virtual, and hybrid) of the ASCO conference on greenhouse gas (GHG) emissions and to recommend sustainable options for future conferences. MATERIALS AND MET…
View article: Addressing the Intersectional Stigma of Kaposi Sarcoma and HIV: A Call to Action
Addressing the Intersectional Stigma of Kaposi Sarcoma and HIV: A Call to Action Open
View article: D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide
D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide Open
Background Standard treatment for newly diagnosed high-grade gliomas remains suboptimal. Preclinical data indicate that mesenchymal transition and radiation resistance in glioblastoma are driven by NF-κB and microglia activation, which can…
View article: Cancer Treatment Decision-Making for People Living With HIV: Physician-Reported Barriers, Facilitators, and Recommendations
Cancer Treatment Decision-Making for People Living With HIV: Physician-Reported Barriers, Facilitators, and Recommendations Open
Background: Compared with the general cancer population, people living with HIV (PLWH) and cancer are less likely to receive treatment and have significantly elevated cancer-specific mortality for many common cancer types. Physician recomm…
View article: Radiation Oncology proceedings from the 2023 Binaytara Summit on Cancer Health Disparities, “Reframing and Addressing Barriers to Adoption of Precision Oncology”
Radiation Oncology proceedings from the 2023 Binaytara Summit on Cancer Health Disparities, “Reframing and Addressing Barriers to Adoption of Precision Oncology” Open
The Binaytara Foundation annual Summit on Cancer Health Disparities is one of the largest clinical and research conferences on cancer disparities in the USA. The 2023 theme was “Reframing and Addressing Barriers to Adoption of Precision On…
View article: Building a Diverse Pathway into Radiation Oncology: The Initial 12-Year Experience of the ASTRO Medical Student Fellowship Program for Underrepresented Populations
Building a Diverse Pathway into Radiation Oncology: The Initial 12-Year Experience of the ASTRO Medical Student Fellowship Program for Underrepresented Populations Open
View article: State of the science and future directions for research on <scp>HIV</scp> and cancer: Summary of a joint workshop sponsored by <scp>IARC</scp> and <scp>NCI</scp>
State of the science and future directions for research on <span>HIV</span> and cancer: Summary of a joint workshop sponsored by <span>IARC</span> and <span>NCI</span> Open
An estimated 38 million people live with human immunodeficiency virus (HIV) worldwide and are at excess risk for multiple cancer types. Elevated cancer risks in people living with HIV (PLWH) are driven primarily by increased exposure to ca…
View article: Cancer treatment delays among cancer patients living with <scp>HIV</scp> during the <scp>COVID</scp>‐19 pandemic in the United States
Cancer treatment delays among cancer patients living with <span>HIV</span> during the <span>COVID</span>‐19 pandemic in the United States Open
Background The COVID‐19 pandemic led to care disruptions across the cancer continuum. It is unknown if immunosuppressed patients with cancer, who may be at higher risk for complications of SARS‐CoV‐2 infection, are disproportionately impac…
View article: Culturally-informed adaptation and psychometric properties of the Cataldo Cancer Stigma Scale in Northern Tanzania
Culturally-informed adaptation and psychometric properties of the Cataldo Cancer Stigma Scale in Northern Tanzania Open
The scale provides valid, culturally-informed measurement of cancer stigma in Tanzania. Future studies should assess associations with care engagement, which will inform interventions to reduce stigma and improve outcomes.
View article: Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer
Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer Open
Objective: People with HIV (PWH) are living longer and experiencing higher numbers of non-AIDS-defining cancers (NADC). Epigenetic aging biomarkers have been linked to cancer risk, and cancer is now a leading cause of death in PWH, but the…
View article: Cancer-Related Stigma in Malawi: Narratives of Cancer Survivors
Cancer-Related Stigma in Malawi: Narratives of Cancer Survivors Open
PURPOSE Stigma is an impediment across the cancer care continuum, leading to delayed presentation to care, elevated morbidity and mortality, and reduced quality of life. The goal of this study was to qualitatively examine the drivers, mani…
View article: Improving Cancer Care for People Living With HIV: A Qualitative Study of Provider Knowledge, Attitudes, and Practice
Improving Cancer Care for People Living With HIV: A Qualitative Study of Provider Knowledge, Attitudes, and Practice Open